ORIC Pharmaceuticals (ORIC) Earnings Analysis

ORIC Pharmaceuticals (ORIC) next reports earnings on 2026-08-11, consensus EPS -0.36 USD. Last quarter (2026-05-04) it missed with EPS -0.34 USD vs -0.32075 USD est (-6%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E -7.47.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ORIC next report earnings?

Next earnings date2026-08-11
Consensus EPS estimate-0.36 USD
Revenue estimaten/a

ORIC earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-04-0.34 USD-0.32075 USD-6%Miss
2026-02-23-0.3 USD-0.34 USD+11.8%Beat
2025-11-13-0.33 USD-0.41 USD+19.5%Beat
2025-05-05-0.42 USD-0.51 USD+17.6%Beat
2025-02-18-0.51 USD-0.52 USD+1.9%Beat
2024-08-12-0.45 USD-0.42 USD-7.1%Miss

Beat rate: 4/6 (67%) over reported quarters with consensus data.

ORIC valuation and analyst view

Trailing P/E-7.47
Trailing EPS-1.28198 USD
Price / book2.73
Dividend yield0.00%
Market cap1.09B
Analyst consensusBuy (10 buy / 0 hold / 0 sell)
Avg price target15 USD

Related research pages

Frequently asked questions

When is ORIC Pharmaceuticals (ORIC)'s next earnings date?

ORIC Pharmaceuticals is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.36 USD.

Did ORIC beat earnings last quarter?

In its 2026-05-04 report, ORIC posted EPS of -0.34 USD versus a -0.32075 USD estimate — a miss of 6%.

What is ORIC's earnings track record?

Over the last 6 reported quarters with consensus data, ORIC beat estimates 4 times (67%).

What is ORIC's current P/E ratio and EPS?

ORIC trades at a trailing P/E of -7.47 on trailing EPS of -1.281980222268941 USD.

What do analysts rate ORIC?

Analyst consensus is "Buy" across 10 ratings (0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 15 USD.